The Drug that Debunks Free Will
Cathy O’Neill joins to talk about the NYSE, algorithms at the IRS, and a miracle weight loss drug.
Listen & Subscribe
Choose your preferred player:
Apple Podcasts
Get Your Slate Plus Podcast
If you can't access your feeds, please contact customer support.
Listen on your computer:
Apple Podcasts will only work on MacOS operating systems since Catalina. We do not support Android apps on desktop at this time.
Listen on your device:RECOMMENDED
These links will only work if you're on the device you listen to podcasts on. We do not support Stitcher at this time.
Set up manually:
Episode Notes
This week, former Slate Money host Cathy O’Neill joins Felix Salmon, Emily Peck, and Elizabeth Spiers to discuss the technical glitch at the New York Stock Exchange. They also talk about a new study that found the IRS disproportionately audits Black taxpayers, and about Ozempic, a shockingly effective – and expensive – weight loss drug.
In the Plus segment: a debate over Slack etiquette.
Podcast production by Anna Phillips.
